SCHEMBL7974768

SCHEMBL7974768

CCOC(=O)C(=CCl)c1cc(-n2c(Cl)nc(C(F)(F)F)cc2=O)ccc1Cl

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.38
LMNA P02545 1/20 0.37
HPGD P15428 3/20 0.36
POLB P06746 2/20 0.35
GAA P10253 1/20 0.35
KMT2A Q03164 4/20 0.35
TDP1 Q9NUW8 2/20 0.34
CTSB P07858 1/20 0.34
MEN1 O00255 3/20 0.34
NOTUM Q6P988 1/20 0.34
MAPT P10636 4/20 0.33
TP53 P04637 1/20 0.33
KDM4E B2RXH2 1/20 0.33
NPY1R P25929 1/20 0.33
NPY2R P49146 1/20 0.33
NPSR1 Q6W5P4 2/20 0.32
ALPL P05186 1/20 0.32
ALPI P09923 1/20 0.32
NSD2 O96028 1/20 0.32
PKM P14618 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7933744 0.81 ALDH1A1 (0.38) ALDH1A1LMNAHPGDPOLBGAA
SCHEMBL7933742 0.81 ALDH1A1 (0.38) ALDH1A1LMNAHPGDPOLBGAA
SCHEMBL7930247 0.77 POLB (0.36) ALDH1A1LMNAPOLBGAAKMT2A
SCHEMBL8137674 0.77 TP53 (0.43) ALDH1A1POLBGAAKMT2ANOTUM
SCHEMBL8138015 0.75 CYP4F2 (0.41) ALDH1A1MAPTTP53NPSR1HSD17B10
SCHEMBL7930248 0.70 POLB (0.36) ALDH1A1LMNAHPGDPOLBGAA
SCHEMBL10411515 0.70 TDP1 (0.48) ALDH1A1POLBGAAKMT2ATDP1
SCHEMBL9423037 0.70 KMT2A (0.38) ALDH1A1POLBGAAKMT2ATDP1
SCHEMBL10531901 0.69 BAZ2B (0.43) ALDH1A1LMNAHPGDGAAKMT2A
SCHEMBL6699195 0.66 CYP4F2 (0.44) ALDH1A1LMNAKMT2ATDP1CTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010031865-A1 Substituted 3-phenyluracils KLINTZ RALF (DE) 2001-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010031865-A1 Substituted 3-phenyluracils CCR1, CCR6, CCR3 ALDH1A1 1864/4885LMNA 1409/4885HPGD 3311/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.